Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA)

83 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q4 2024.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.38M shares of 17.3M outstanding shares and own 54.33% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.7M shares), ACORN CAPITAL ADVISORS, LLC (1.29M shares), Solas Capital Management, LLC (1.27M shares), VANGUARD GROUP INC (797K shares), Newtyn Management, LLC (570K shares), Prosight Management, LP (467K shares), BlackRock, Inc. (344K shares), RBF Capital, LLC (339K shares), RENAISSANCE TECHNOLOGIES LLC (238K shares), and Verition Fund Management LLC (207K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.